)
)
Evotec Investor Relations Material
Latest events
Q3 2024
Evotec
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Evotec SE
Access all reports
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is focused on the identification of novel medicines that improve the lives of patients with significant unmet medical needs, principally in oncology, inflammation, metabolic disorders and rare diseases. In addition to the development of its own pipeline of small molecule drugs, Evotec also develops new drugs for its partners through discovery programs in high value areas such as immuno-oncology, neuroscience and inflammation.
Key slides for Evotec SE
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
EVT
Country
🇩🇪 Germany